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The Evolution of Scholarship on the
Cutting Edge

Law & Health Care Faculty members (bottom row from l-r) Leslie Meltzer Henry, Virginia Rowthorn, Amanda Pustilnik, Richard
Boldt, (top row from l-r) Kathleen Hoke, Ellen Weber, Diane Hoffmann, Frank Pasquale (not pictured:
Michael Greenberger, Karen Rothenberg and Deborah Weimer)

In the Fall of 2003, we devoted an issue of the Law & Health Care
Program (L&HCP) newsletter to Scholarship on the Cutting Edge. In
the introduction to that issue – which focused on the work of our faculty – we noted that “the field of health law offers a multitude of issues
for thought-provoking scholarship ranging from whether or not to allow
human cloning or whether to regulate IVF and genetic testing … to health
insurance and fraud and abuse.” Over a decade later, these same issues
continue to raise bedeviling and complex questions as science develops
and the health care system evolves. As the L&HCP enters its 30th year
of existence, cutting edge scholarship is still at the forefront of our program. This pursuit is enhanced by the synergistic effect that having a
critical mass of health law scholars in one place creates. As our faculty
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has grown, so has the breadth of the health law topics we study. This has
created valuable intersections that are reflected in our scholarship, teaching, and in our clinics. For instance, scholarship by some of our faculty
members relating to how medical marijuana should be regulated dovetails
with the work of our drug policy and public health law clinics. Research
on the use of “big data” in health care naturally implicates the work of
our faculty members who focus on human subjects research and policies
surrounding the use of genetic and other health information. Professors
who focus on mental health law have collaborated with faculty who are
focused on neuroscience and addiction to explore issues surrounding
adolescent decision making for health care decisions. We also find many
opportunities to work with the L&HCP’s affiliated scholarly centers (including the Center for Health and Homeland Security and the Network for
Public Health Law) as well as faculty members from the different professional schools on the University of Maryland campus. The L&HCP is
more than the sum of its parts. Over time it has become a lively group of
scholars who respond to and, equally as important, raise critical questions
in health law that can often only be answered through a collaborative approach. This evolution over 30 years is reflected in the following update
on the current work of L&HCP faculty members.
Professor Diane Hoffmann
Professor Diane Hoffmann has directed the
L&HCP at the Carey School of Law since 1999.
Since joining the faculty, her scholarship has
primarily followed two strands: one focusing on
legal and ethical issues in end of life care and the
treatment of pain; the second on the use and regulation of new health-related technologies, products
and procedures. These two areas of scholarship
stemmed from joint appointments when she came
to the law school—one with the campus Geriatrics and Gerontology Education and Research
Prof. Diane Hoffmann
(GGEAR) Program, the other with the University’s
Program on Public Issues in Biotechnology, which, at the time, was a
program of the Maryland Biotechnology Institute.
Over the last decade her earlier focus on end of life care evolved into a
focus on legal obstacles to the treatment of pain and arguments for more
rational laws and enforcement of laws related to physician prescribing of
opioids, see e.g. “Treating Pain v. Reducing Drug Diversion and Abuse:
Recalibrating the Balance in Our Drug Control Laws & Policies,” 1 St.
Louis University Journal of Health Care Law and Policy 231 (2008).
Her numerous articles on this topic led her to write a “Perspective” piece
for the New England Journal of Medicine on medical marijuana and the
law—both opioids and marijuana are scheduled substances under the
Controlled Substances Act. In that piece, co-authored with Prof. Ellen
Weber, the authors argued that moving marijuana from a Schedule I to
a Schedule II substance would allow for a more rational approach to
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Since joining the faculty, Professor
Hoffmann's scholarship has primarily
followed two strands: one focusing on legal
and ethical issues in end of life care and
the treatment of pain; the second on the
use and regulation of new health-related
technologies, products and procedures.
advancing effective cannabinoid based medical treatment. As a result of the article, Hoffmann has given
numerous talks at conferences around the country on
the legal issues associated with state medical marijuana laws and continues to follow the growing state
legislation on this topic.
Consistent with the second strand of her research, in
2009 Hoffmann received a three year grant from the
NIH under the ethical, legal and social issues (ELSI)
program of the Human Microbiome Project (HMP).
The grant was awarded to Hoffmann, who was the
Principal Investigator on the project, along with coinvestigators at Maryland’s schools of law, medicine
and pharmacy, to examine the current regulation of
probiotics, i.e., substances containing live microorganisms that have a beneficial effect when taken in sufficient quantities by manipulating microbiome and host
properties. Hoffmann formed a working group of scientists doing research on the human microbiome, food
and drug law attorneys, health law professors, industry
representatives, consumer advocates, and regulators
from the Federal Trade Commission and the Canadian Health Products Directorate, to examine whether
the current U.S. regulatory framework for probiotics
adequately addresses issues of safety and effectiveness, provides sufficient information to consumers to
make informed choices about probiotic products, and
does not discourage research on potential therapeutic
benefits of these products. The project resulted in
a White Paper and articles in Science (“Probiotics:
Finding the Right Regulatory Balance,” Oct. 2013),
Beneficial Microbes (“Health Claim Regulation in the
EU and the US: Which is the Better Approach,” 2013)
and the Journal of Food & Drug Law (“Probiotics:
Achieving a Better Regulatory Fit,” 2014). Hoffmann
is also working, with colleague Jack Schwartz, on a
fourth article resulting from this project on establish-

ing a modified private right of action under the Federal
Trade Commission Act for false or unsubstantiated
health claims.
The ELSI project also led Hoffmann to co-author
(with Dennis Fortenberry MD, MS and Jacques Ravel,
PhD) another article about legal and ethical issues in
human subject research generated by the HMP. The
article was part of a special volume of the Journal of
Law, Medicine & Ethics, guest edited by Carey Law
Professor Leslie Meltzer Henry, on proposed changes
to the federal Common Rule for conducting research
on human subjects. In the piece, “Are Changes to the
Common Rule Necessary to Address Evolving Areas
of Research? A Case Study Focusing on the Human
Microbiome Project,” Hoffmann and her co-authors
explore ways in which research conducted under the
HMP, like research conducted under the Human Genome Project, raises challenging issues for regulation
of human subjects research, particularly issues related
to subject selection and recruitment, group stigma, and
information risks. She will be speaking on this topic
at an upcoming meeting of the Institute of Medicine.
Next on Hoffmann’s research list is an examination
of the potential regulatory frameworks for microbiota
transplants.
Professor Richard Boldt
Professor Richard Boldt has
been on the University of Maryland faculty since 1989. He
teaches and writes in the areas
of constitutional law, criminal
law, mental disability law and
torts and has a special research
interest in legal issues surrounding mental health and drug use
disorders. Professor Boldt has
Prof. Richard Boldt
three recent articles, including
two coming out in the next few
months, which reflect his deep interest in these areas
from both a research and advocacy perspective.
The first paper, “The ‘Voluntary’ Inpatient Treatment
of Adults Under Guardianship,” which will appear
in Volume 60, Issue 1 of the Villanova Law Review,
tackles a gap in the laws that relate to hospitalization
of adults under guardianship. Boldt’s interest in the
issue was generated by an inquiry from a practitioner
in Washington, DC and subsequently developed into

3 │ Law & Health Care Newsletter

a full blown research project when Boldt realized that
the answer was not only complicated but variable
across states and jurisdictions. A number of states
have adopted a preference for voluntary hospitalization over involuntary civil commitment for adults with
severe mental illness who require inpatient treatment.
Frequently, however, the disabilities that call for
inpatient treatment also disrupt an individual patient’s
capacity to participate fully in the decision-making
process by which hospital admission is elected. The
appointment of a guardian for some of these patients
could provide a solution to this problem, but a range
of statutory and case law limitations complicate matters. Boldt’s article provides a brief history of the
law in this area, explores the role that informed consent plays in voluntary hospitalizations, provides an
analysis of the interests in tension when a guardian
is appointed, and offers a framework for an effective statutory approach that would allow guardians to
arrange for voluntary hospitalization of a ward if the
substantive standards and procedural requirements put
in place by state law are adequate to insure that thirdparty decision-makers are acting with respect for the
values held by these patients and, to the extent possible, are seeking to serve their best interests.
In Boldt's recent article in the Maryland Law Review
about problem-solving courts, he steps back from the
mechanics of such courts to conclude that the practice
is—to date—undertheorized and to urge that pragmatist theory be employed to guide the development of
these courts.
In an article on a related theme, “Perspectives on
Outpatient Commitment,” which will appear in Volume 49, Issue 1 of the New England Law Review,
Boldt discusses research that he began as part of an
initiative that he worked on with L&HCP Professors
Diane Hoffmann and Amanda Pustilnik regarding
outpatient civil commitment, also known as “assisted outpatient treatment” (AOT) or “mandatory
outpatient treatment.” The initiative was convened to
discuss whether stakeholders in Maryland might be
able to reach consensus on a path to improving access
to outpatient mental health care in Maryland. As part
of this initiative, Professor Boldt studied legislative
approaches to outpatient commitment. Boldt’s most
recent article on the issue discusses proposed legislation at the federal level, including a bill introduced in

In Boldt's recent article in the Maryland Law
Review about problem-solving courts, he
steps back from the mechanics of such courts
to conclude that the practice is—to date—
undertheorized and to urge that pragmatist
theory be employed to guide the development
of these courts.
the fall of 2013 by U.S. Representative Tim Murphy
entitled the “Helping Families in Mental Health Crisis
Act of 2013,” which was fashioned to reform a number of existing policies and practices and included
a controversial provision designed to encourage the
states to make greater use of outpatient civil commitment. The Murphy reform bill was met in the House
of Representatives by an alternative set of proposals
developed by Representative Ron Barber to increase
funding for community-based treatment. The Barber
bill did not include provisions to encourage the use
of outpatient commitment or other forms of enforced
community-based care. Boldt’s article provides a brief
history of the law governing involuntary civil commitment in the United States and reviews the available data on the outcomes of involuntary outpatient
treatment, particularly with respect to subsequent
hospitalizations and criminal system involvement, and
concludes with a summary assessment of the considerations pushing for and against the greater adoption of
outpatient commitment.
Professor Michael Greenberger
Professor Greenberger is the
Director of the University of
Maryland Center for Health and
Homeland Security (CHHS),
an academic and non-profit
consulting entity with over 60
professionals on staff working
on over 90 contracts worldwide. Among CHHS’ key areas
of expertise are public health
emergency preparedness and response, medical surge planning,
mass fatality planning, training
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Prof. Michael
Greenberger

and exercises, interoperability, cybersecurity, continuity of government, continuity of operations, critical
infrastructure protection, and energy resilience. (More
information about CHHS can be found at www.umaryland.edu/healthsecurity/ and at www.mdchhs.com.)
Over the past year, Professor Greenberger has spoken on a number of issues related to biosecurity and
dual use of research of concern. This research may
provide knowledge, information, products, or technologies that could be directly misapplied to pose a
significant threat with broad potential consequences to
public health and safety and national security. Earlier
this year Greenberger spoke on this topic as a panelist at an AALS session entitled, “Risk and Regulation: Biosecurity and the Law.” In February, Professor
Greenberger led CHHS’ efforts to coordinate with
the Middle Atlantic Regional Center of Excellence
for Biodefense and Emerging Infectious Diseases
(MARCE) to host a conference on “Laboratory and
Public Safety Preparedness for Dual Use Research of
Concern.” The MARCE Conference brought professionals from emergency management, public health,
the legal community, and federal, state and local
governments together to address how to properly
balance the ability to conduct biological research on
potentially lethal pathogens with the implementation
of appropriate protective biosafety mechanisms to
prevent against the accidental or intentional release of
such pathogens.
Professor Greenberger currently serves by appointment of the Governor of Maryland on the Commission
on Maryland Cybersecurity Innovation and Excellence
and is a member of the Baltimore Washington Cyber
Task Force. Additionally, he was recently appointed

Professor Greenberger has spoken on a
number of issues related to biosecurity
and "dual use of research of concern."
This research may provide knowledge,
information, products, or technologies
that could be directly misapplied to pose
a significant threat with broad potential
consequences to public health and safety and
national security.

to serve on the Editorial Board for the Disaster and
Military Medicine journal; on the Committee on Science, Technology, and Law at the National Academy
of Sciences; and previously served as the Chair of the
Maryland Governor’s Emergency Management Advisory Council.
Recognized as a national expert in a number of
areas, Professor Greenberger is called upon frequently
to provide analysis and commentary on issues such
as domestic and international responses to naturallyoccurring and man-made emergencies; biosecurity
and laboratory safety; counterterrorism strategies; and
cybersecurity law and policy.
Professor Leslie Meltzer Henry
Professor Leslie Meltzer Henry joined the law
school faculty in 2008. In addition to teaching at the law
school, she is a faculty member
at the Johns Hopkins Berman
Institute of Bioethics. The focus
of Professor Henry’s teaching
and scholarship is constitutional
law, bioethics, public health law
and policy, reproductive justice,
and research ethics.
Prof. Leslie Meltzer
Professor Henry is workHenry
ing with colleagues at Johns
Hopkins on a project about the
concept of dignity in law and medicine. The project,
funded by a grant from the Gordon and Betty Moore
Foundation, is designed to study and make recommendations regarding the loss of dignity that patients
may experience in intensive care units (ICU). The first
phase of the grant came to a close this summer. Henry
was the team lead for the component of the grant that
involved conceptualizing the meaning of dignity in
the ICU. Based on the conceptual model the team
created, Henry co-wrote an article entitled, “Respect
and Dignity: A Conceptual Model for Patients in the
ICU,” in Narrative Inquiry in Bioethics (forthcoming
2014). The article notes that, although the concept of
dignity is commonly invoked in clinical care, there is
not widespread agreement—in either the academic literature or in every-day clinical conversations—about
what dignity means. This makes it difficult to determine what threatens patients’ dignity and, conversely,
how to honor commitments to protect and promote
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Professor Henry is working with colleagues
at Johns Hopkins on a project about the
concept of dignity in law and medicine. The
project, funded by a grant from the Gordon
and Betty Moore Foundation, is designed
to study and make recommendations
regarding the loss of dignity that patients may
experience in intensive care units.
it. The article presents the first conceptual model of
dignity for patients in the ICU based on the notion
that there are three sources of patients’ dignity—their
shared humanity, personal narratives, and autonomy—each of which independently warrants respect.
The article describes each source of dignity and draws
on examples to illustrate how clinician attitudes, actions, and behaviors can either contribute to, or detract
from, expressions of respect for patient dignity.
Professor Henry is also continuing her work on ethical and legal protections for human research subjects.
Last summer, she edited a symposium issue of The
Journal of Law, Medicine & Ethics entitled “Revising
the Common Rule: Prospects and Challenges.” This
symposium issue of the journal grew out of a roundtable the L&HCP sponsored with the Berman Institute
to address an Advance Notice of Proposed Rulemaking (ANPRM) that was circulated for comment to
every federal agency regarding updates to the Common Rule – the regulations governing use of human
subjects in government-funded research. In addition
to discussing the topic areas identified in the ANPRM
as focal points for change, participants also considered
mechanisms for enhancing research protections that
might require amending the Common Rule beyond the
ANPRM’s proposals. The conversations and presentations at the Roundtable resulted in seven papers in the
symposium issue of the journal. Henry wrote an article
published in that issue about why the United States
has not developed a no-fault compensation system for
injured research subjects. That article is called “Moral
Gridlock: Conceptual Barriers to No-Fault Compensation for Injured Research Subjects.” In relation to this
scholarship, Professor Henry has made presentations
to the staff of the Presidential Commission for the

Study of Bioethical Issues, at the Health Law Professors’ Conference, and the Johns Hopkins Berman
Institute of Bioethics Seminar Series.
On another front, Professor Henry is a team member
on an NIH-funded grant entitled “PHASES—Pregnancy and HIV/AIDS: Seeking Equity Study.” The project
aims to understand and remedy the underinclusion of
pregnant women, women of childbearing potential,
and women who are lactating from HIV/AIDS clinical trials. Stemming from this initiative is an article
she is co-authoring with the team that explores how
the current legal and regulatory framework for human
subjects research may contribute to the underinclusion
of women. The research team is holding a meeting in
November with legal stakeholders (general counsels
from the pharmaceutical industry and major research
institutions, former FDA regulators, and food and drug
lawyers) in this area to inform the team’s work.
In a different but related vein, Professor Henry has
been doing some writing about the ethical and legal
aspects of the Facebook Study that was recently in the
news. Facebook generated anger among some members of its social network after a study was published
based on manipulations of its users' news feeds. The
study involved altering the news feeds of roughly
689,000 users to determine whether positive or negative content would affect their emotions and subsequent Facebook updates. Henry was quoted in the
Wall Street Journal and ABCNews.com commenting
on the study, and with UM Carey Law faculty member
James Grimmelman, she co-authored several impact
letters to the involved parties that aim to improve research protections for consumers of social media.
Professor Kathleen Hoke
Professor Kathleen Hoke directs the Legal Resource
Center for Public Health
Policy, funded by the Maryland Department of Health
and Mental Hygiene, and the
Network for Public Health
Law’s Eastern Region, funded
by the Robert Wood Johnson
Foundation. Hoke teaches
the Public Health Law Clinic
through which she engages
law students in the work of the Prof. Kathleen Hoke
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Network and the Center.
Through the Legal Resource Center (LRC) (www.
law.umaryland.edu/programs/publichealth), Hoke
provides technical legal assistance to Maryland state
and local health officials, legislators, and organizations working in tobacco control, obesity reduction,
and injury prevention. Recent work has focused on
the regulation of cigars and electronic cigarettes,
the development of sound policies to create smokefree multiunit housing, legislation to prevent injury
by requiring seatbelts for all vehicle occupants, and
legislative mandates that childcare facilities serve only
healthy beverages.
The Network for Public Health Law (www.networkforphl.org) provides technical legal assistance
to national, state and local public health professionals, their attorneys, legislators, researchers, and advocates working to develop sound public policy to
improve public health. This assistance often results
in the creation of fact sheets, issue briefs, 50-state
surveys, webinars, and other useful tools on emerging and persistent public health issues. Under Hoke’s
direction, the Network’s Eastern Region deliverables
have focused on environmental health, food safety and
injury prevention.
In addition to contributing to, and supervising LRC
and Network products, Hoke writes about emerging
issues in tobacco regulation. Hoke has authored legal
synopses published by the Tobacco Control Legal
Consortium, including Regulating Tobacco Advertising and Promotion: A ‘Commerce Clause’ Overview
for State and Local Governments, and filed petitions
with the Food and Drug Administration requesting
the agency take a more flexible approach to regulating nicotine replacement therapy and to expanding
regulatory power over cigars. Professor Hoke has also
filed amicus curiae briefs with the Supreme Court in
two tobacco cases, Rowe v. New Hampshire Motor
Transport (cited in Justice Ginsburg’s concurrence)
and Altria v. Good. In 2011, Hoke co-authored an
op-ed piece for the Jurist Forum, commenting on the
Supreme Court’s First Amendment case, Sorrell v.
IMS Health. Recently she co-authored an op-ed piece
for the National Law Journal on the $23 billion jury
verdict in Johnson v. R.J. Reynolds, a civil case in
Florida.
Hoke also engages in interdisciplinary collaboration
which has resulted in publications in social science

Hoke has authored legal synopses published
by the Tobacco Control Legal Consortium,
including "Regulating Tobacco Advertising
and Promotion: A ‘Commerce Clause’
Overview for State and Local Governments,"
and filed petitions with the Food and Drug
Administration requesting the agency take a
more flexible approach to regulating nicotine
replacement therapy and to expanding
regulatory power over cigars.
journals, including articles on hookah smoking published in the American Journal of Public Health and
in Nicotine and Tobacco Research and on cigar packaging published in Progress in Community Health
Partnerships: Research, Education, and Action.
Professor Frank Pasquale
Professor Frank Pasquale joined the Law & Health
Care Program in 2013 and teaches Administrative
Law, Health Care Law and
Policy, and the Health Information Privacy and Innovation seminar. These courses,
as well as numerous note and
comment supervisions, allow
Pasquale to share his deep
interest and background in
information law with our students. In classes and research,
they explore how technolProf. Frank Pasquale
ogy is changing the role and
impact of information in our
lives.
While Pasquale's past legal scholarship has explored
ways of advancing the use of technology in health
care, his new book The Black Box Society explains
how principles of health care policy should inform
internet regulation. For example, Pasquale argues
that consumers should be able to access all data held
about them, not just health data, because health status
can be inferred from data not covered under HIPAA.
The book was cited in the White House Report on Big
Data, and Pasquale will be giving book talks at Yale,

7 │ Law & Health Care Newsletter

SUNY-Buffalo, the University of Virginia, and several
other institutions.
In addition to his new book, Pasquale addressed data
policy in the health care industry in several venues
over the summer. In June, Pasquale and Professor Melissa M. Goldstein of George Washington University’s
School of Public Health presented a report on a panel
titled “Exploring Legal Challenges to Fulfilling the
Potential of mHealth in a Safe and Responsible Environment,” to members of the American Association for
the Advancement of Science (AAAS) Working Group
on mHealth (the use of mobile communications in
health care). The panel focused on regulation, guidelines, and policies relating to mHealth which raise
questions about the type of regulatory framework that
will both facilitate innovation and deployment of new
technologies, and protect patients.
Professor Pasquale also presented on data policy at
the Health Privacy Summit at Georgetown Law Center
in June. The Summit brought together national and international privacy experts from academia, along with
healthcare providers, information technology specialists, industry representatives, and government officials
to hear insights, ideas, and analysis from leaders in
the health privacy community. The Summit focused
on patient identification issues, mobile application
privacy, international cybersecurity, and research data.
Pasquale spoke on a panel titled “Privacy, Big Data,
and Mobile: Technologies Operating Outside HIPAA
Protection.”
In addition to these projects, Pasquale was appointed
to a University of Maryland committee exploring
the ethical, legal, and social implications of big data

While Pasquale's past legal scholarship has
explored ways of advancing the use of technology in health care, his new book The
Black Box Society explains how principles
of health care policy should inform internet
regulation. For example, Pasquale argues
that consumers should be able to access all
data held about them, not just health data,
because health status can be inferred from
data not covered under HIPAA.

research. He has also joined the Council for Big Data,
Ethics, and Society, a national committee of academics in data science, law, informatics, and social
science, supported through a grant by the National
Science Foundation as part of the National Big Data
Initiative. The Council meets four times a year and
publishes reports in order to help researchers, practitioners, and the public understand the social, ethical,
and legal issues that underpin the "big data" phenomenon.
In addition to his work in the area of big data, Professor Pasquale has written and presented on other
topics. His article “Private Certifiers and Deputies
in American Health Care” was recently published in
the North Carolina Law Review. At the Privacy Law
Scholars Conference in June, Pasquale and UM Carey
Law Professor Danielle Citron’s paper “The Scored
Society: Due Process for Automated Predictions,” was
selected out of the over 60 papers presented for an
award from the International Association of Privacy
Professionals for “overall excellence and relevance to
the profession of privacy.” Another Pasquale proposal
on automation and the professions was selected by Triple Canopy, an arts and culture organization based in
New York, as one of seven commissions chosen from
over 350 applications in 2014. The paper includes
sections on legal and medical automation. Pasquale
published an early draft version of part of the paper as
a blog post, which was praised by the President of the
American Association of Law Schools (Dan Rodriguez) as “an extraordinarily thoughtful, informed perspective on the ‘machine v. lawyers’ ” debate.
Professor Amanda Pustilnik
Amanda C. Pustilnik is an Associate Professor of
Law at the University of Maryland School of Law,
where she teaches Criminal
Law, Evidence, and Law &
Neuroscience. Her current research includes work on models of mind in criminal law,
evidentiary issues presented by
neuroscientific work on memory, and how neuroscience can
help the law reconceptualize its
approaches to questions involving physical and emotional
Prof. Amanda Pustilnik
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pain in legal domains ranging from tort to torture.
As part of her ongoing scholarship in the area of
neuroscience and the law, in April of this year, Professor Pustilnik organized two L&HCP events. The first
event was the L&HCP’s annual Rome Lecture which
was given this year by Stanford Law Professor Hank
Greely on the topic of “Neuroimaging, Mindreading,
and the Courts.” Professor Greely’s talk was a kick
off to the interdisciplinary roundtable that took place
the following day on the topic of “Imaging Brains,
Changing Minds: Chronic Pain Neuroimaging and
the Law.” The roundtable was designed to create a
dialogue between the fields of law and neuroscience
and to make legal actors aware of recent breakthrough
work in neuroimaging that has led to a paradigm shift
in understanding chronic pain. Professor Pustilnik

During the Spring 2015 semester, Professor
Pustilnik will serve as the first Senior Fellow
in Law and Neuroscience at the Center for
Law, Brain & Behavior at Massachusetts
General. As a Fellow, Pustilnik will pursue
original research, mentoring, and public
engagement related to issues of pain and the
law.
organized and moderated the roundtable in collaboration with Dr. David Seminowicz from the Department of Neural and Pain Sciences at the University of
Maryland School of Dentistry, and with the support
of the American Association for the Advancement of
Science’s Scientific Responsibility, Human Rights and
Law Program. Prominent legal academics, scientists
and judges attended the roundtable. Pustilnik is currently working with several of the participants in the
roundtable on articles that will appear in an upcoming
symposium issue of the L&HCP’s Journal of Health
Care Law & Policy next year.
During the Spring 2015 semester, Professor Pustilnik
will serve as the first Senior Fellow in Law and Neuroscience at the Center for Law, Brain & Behavior at
Massachusetts General. As a Fellow, Pustilnik will pursue original research, mentoring, and public engagement related to issues of pain and the law. The Center
is a collaboration between Massachusetts General
Hospital and Harvard Law School and was created to

look at questions that arise as science, law, finance and
public policy intersect such as whether brain imaging
can distinguish truth from falsehood or predict who
will become violent and determine how to prevent
it. The Center addresses these issues by monitoring
relevant brain discoveries; promoting neuroscience
that is responsible, ethical and scientifically sound; and
discouraging premature or inappropriate use of scientific findings.
Professor Karen Rothenberg
Professor Karen Rothenberg, the founding director
of the L&HCP, is currently on leave from the L&HCP,
serving as Senior Advisor on Genomics and Society
to the Director of the National
Human Genome Research Institute (NHGRI) and a visiting
scholar at the National Institutes of Health Department of
Bioethics.
As we noted in the Spring
2014 edition of the L&HCP
newsletter, in addition to her
work on a variety of genetic policy issues, Professor Prof. Karen Rothenberg
Rothenberg’s current research
focuses on the use of theatre
as an innovative tool to identify and encourage discussion of the unique ethical, legal and social issues
posed by emerging technologies in health care. This
year, Rothenberg and her colleague Dr. Lynn Bush
of Columbia University Medical Center, published a
book, The Drama of DNA: Narrative Genomics. The
book uses excerpts from Rothenberg and Bush’s original plays and plays by other authors to examine the
implications of genomic technologies in today’s soci-

In April, Rothenberg moderated a discussion
at the Smithsonian in Washington, DC
with several contemporary playwrights who
have used theatre to examine the ethical,
legal, and social issues that genomics have
introduced into our lives, as well as to
stimulate conversations about biomedical
research.
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ety as well as to foster a greater understanding of how
genomic information should be evaluated, processed,
and shared. The book links readers to online versions
of their original plays and is designed to serve as a
resource to health care providers, researchers, patients,
and their families.
Rothenberg’s collaboration with Dr. Bush, which began when Rothenberg spent academic year 2009-2010
on sabbatical as a Scholar-in-Residence at Columbia
Law School, has been a fruitful one. They have coauthored many short plays to help convey the complexity of ethical issues raised by genomic research.
Their plays were presented at an Ethical, Legal, and
Social Issues (ELSI) Congress sponsored by NHGRI
and have been performed by interdisciplinary groups
of professionals in Australia, the Netherlands, and
London and at the annual meetings of the American
Society of Human Genetics, the American Society for
Bioethics and Humanities, National Society of Genetic
Counselors, Public Responsibility in Medicine and
Research (PRIM&R), and several institutes within
NIH. Recently Rothenberg engaged the staff of the
Presidential Commission for the Study of Bioethical
Issues in reading one of the plays aloud.
In April, Rothenberg moderated a discussion at the
Smithsonian in Washington, DC with several contemporary playwrights who have used theatre to examine
the ethical, legal, and social issues that genomics
have introduced into our lives, as well as to stimulate
conversations about biomedical research. Playwrights
Dorothy Fortenberry (The Good Egg), Lisa Loomer
(Distracted), Cassandra Medley (Relativity), and Anna
Ziegler (Photograph 51) discussed why and how they
used complex topics rooted in genetics —including issues of identity, the power of genetic information, and
the impact of health decisions on family dynamics—in
their work. The program was designed to complement
the National Museum of Natural History exhibition
“Genome: Unlocking Life's Code,” which is co-sponsored by NHGRI and for which Rothenberg was asked
to conduct public outreach. Rothenberg is planning
future programs in conjunction with the exhibit which
will travel to science museums around the country and
Canada over the next few years.
In addition to her theatre-related work, Rothenberg
recently co-authored a paper in the Georgetown Law
Journal titled “Finding Fault? Exploring Legal Duties

to Return Incidental Findings in Genomics Research,”
which deals with the issue of incidental findings that
come up when the whole genome of an individual is
sequenced.
Professor Ellen Weber
Professor Ellen Weber created and teaches the Drug
Policy and Public Health Strategies Clinic in which
she and her clinic students focus on policy development to expand access to substance use treatment services
and represent clients who face
discrimination based on their
history of drug dependence.
Over the past four years, Weber
has focused her clinic work and
scholarship on the implementation of the Affordable Care Act
in Maryland and the Mental
Health Parity and Addiction EqProf. Ellen Weber
uity Act. The Clinic has received
two multi-year grants from the Open Society Foundation to support this work with the goal of ensuring that
Maryland’s consumers benefit from the significant
expansion of drug treatment services under the ACA.
One component of Weber’s health care reform
implementation projects grew out of her 2013 article
on the Parity Act, “Equality Standards for Health
Insurance Coverage: Will the Mental Health Parity
and Addiction Equity Act End the Discrimination,”
published in the Golden Gate University Law Review.
The article explored the Parity Act’s expansive nondiscrimination standards which, according to Weber,
could address many of the health plan design features
that have historically limited access to substance use
and mental health treatment through private insurance.

Looking ahead to the second year of ACA
implementation, Professor Weber and her
Clinic students will help develop strategies
to ensure that persons entering and leaving
local jails are enrolled in health insurance
plans and that individuals maintain
insurance coverage and have effective appeal
rights.
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In the article, Weber recommended strategies that
would ensure more effective enforcement of the Parity
Act by state insurance departments.
Weber has tested her recommendations for achieving enforcement of the Parity Act in Maryland through
her clinic practice. Over the past three years, Weber’s
students have advocated for legislation in the Maryland General Assembly that would require insurance
carriers to report key data points to the state insurance
administration to facilitate the State’s review of plans
for parity compliance. This would address one of the
key barriers to consumer enforcement of the Parity
Act. Most recently, Weber’s clinic students investigated whether the roughly eighty individual health
plans offered in 2014 through Maryland’s marketplace
complied with the Parity Act. The students identified
significant gaps in the carriers’ assessment of plan
features for parity compliance and the State’s review
of plan compliance. As a result of this work, the Clinic
has asked the Centers for Medicare and Medicaid
to intervene to ensure that the State’s 2015 health
plans meet the ACA’s standards for mental health and
substance use benefits. Weber and her students have
also provided extensive community education about
the expanded drug and mental health treatment that is
available under the ACA and have compiled a set of
“Frequently Asked Questions” that responds to provider and consumer questions about those services under
private and public insurance. Looking ahead to the
second year of ACA implementation, Professor Weber
and her Clinic students will help develop strategies to
ensure that persons entering and leaving local jails are
enrolled in health insurance plans and that individuals
maintain insurance coverage and have effective appeal
rights. Weber plans to address the lessons she is learning through the Clinic’s ACA implementation work in
her future scholarship.
In relation to her work, Weber has given several
recent presentations recently to the Tuerk Conference
(sponsored by the National Council on Alcoholism and
Drug Dependence of Maryland), the Maryland Mental
Hygiene Administration’s Annual Conference, and
the Preventing and Treating Substance Use Disorders
2014 Conference (sponsored by Community Catalyst).
Professor Deborah Weimer
Professor Weimer has directed the Health Care
Delivery and HIV/AIDS Clinic at the University of

Maryland Carey School of Law since 1988. She developed the HIV Clinic - as it
is known - as an interdisciplinary effort and has worked with
medical providers and social
work staff at the Evelyn Jordan
Clinic, as well as the Pediatric
HIV Clinic at the University
of Maryland Medical System
(UMMS), for many years. She
and her students have successfully represented clients living Prof. Deborah Weimer
with HIV in a wide range of
civil cases since the early years
of the epidemic. She and her students have also been
involved in legislative advocacy on the state level
to improve conditions for individuals and families
living with HIV illness. The HIV Clinic receives annual grant support from the Maryland Legal Services
Corporation and the Ryan White Foundation and also
works closely with the campus-wide JACQUES Initiative which provides medical, social, and legal services
to individuals living with HIV.
Professor Weimer’s scholarship has focused on the
value and challenges of interdisciplinary practice. She
has also advocated for legislative reform to respond to
the needs of families impacted by HIV. In 2011, she

Professor Weimer’s newest research focuses
on the impact that access to legal services
can have on the health and welfare of
people living with HIV illness. While an
interdisciplinary approach to patient care in
the context of HIV is well accepted, little data
exists to measure the impact of integrating
legal services into an interdisciplinary care
setting.
co-authored a book chapter titled “Patients and Families Living with HIV/AIDS,” that appeared in Poverty,
Health and Law Readings and Cases for MedicalLegal Partnership (Elizabeth Tobin Tyler et al. eds.).
This book is the first of its kind to comprehensively
describe the role of law and lawyers in helping to address and mitigate social disparities in health care in
Cont. on page 18
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alumni news
Michael R. Ulrich Named Senior Fellow in Health Law at
Yale Law School
2011 L&HCP graduate Michael Ulrich was recently named Senior Fellow in
Health Law and Research Scholar in Law at Yale Law School. Michael was a
very active member of the L&HCP, acting as President of the Student Health
Law Organization, participating in the first health law service trip to the Mississippi Delta, and serving as the Manuscripts Editor for the Journal of Health
Care Law & Policy. For all his accomplishments at the law school, he earned
the Public Service Award. Before joining the Yale Law School, he worked
as a bioethicist in the Division of AIDS at the National Institutes of Health,
where he reviewed clinical research protocols and grants, and performed ethics
consultations. Other projects included identifying ethical issues in HIV cure
research, addressing problems with international specimen sharing, and ways
to improve tailoring HIV research to vulnerable populations. He also earned
an M.P.H. from the Harvard School of Public Health in their Law and Public
Health program. His articles have been published in the Yale Journal of Law & Feminism, Michigan State
University Journal of Medicine & Law, and American Journal of Bioethics, among others.

Delora Sanchez Selected for Prestigious Marshall
Memorial Fellowship
Delora Sanchez, who graduated from the law school with the Health Law
Certificate in 2006, was recently selected by the German Marshall Fund of the
United States to be a Marshall Memorial Fellow. Founded in 1982, the Marshall Memorial Fellowship provides a unique opportunity for emerging leaders
from the United States and Europe to build an understanding of politics, business, innovation, and culture on the other side of the Atlantic. For Fellows, it
is an intensive learning and networking experience that begins with six months
of preparations and ends with 24 days of immersion across the Atlantic. The
German Marshall Fund selects 75 Marshall Memorial Fellows each year from
35 nations. The fellows are selected from business, government, and civil society. Delora is Associate Director of State Affairs at the Johns Hopkins Health
System Corporation in Baltimore and an active contributor to the L&HCP. She
will leave on October 16th and spend time in Brussels, Freiburg, Rome, Tirana,
and Paris. To learn more about the health care system in Europe, she has arranged to meet with leaders in the health care industry in Belgium, Italy, and Germany. In Tirana, she plans
to investigate the “concrete mushroom” project which aims to repurpose concrete bunkers that were built
when Albania was in isolation. According to Sanchez, a Baltimore native, “I am hoping to take some ideas
and apply them to Baltimore’s over 16,000 vacant buildings.”
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A Record 48 Graduates Earn the
Health Law Certificate

2014 Health Law Certificate Graduates

At a breakfast reception held on May 14, a record
48 students were awarded the Health Law Certificate.
Professor Diane Hoffmann, Director of the Law &
Health Care Program (L&HCP), and L&HCP faculty
members presented the certificates to the students and
spoke about each student individually to the crowd
of friends and family. This tradition of honoring each
individual student who gets the certificate has become
an institution at the law school. The comments—
written by faculty members who get to know the
students through classes, clinics and externships—
range from laudatory to comical but never fail to
impress the visiting guests with the incredible breadth
of activities the students undertake in their three
years at the law school. The picture that emerged at
the reception was that of a group of students who
will become vibrant and valuable members of the
professional world of health lawyers. In her comments
at the reception, Hoffmann called the 2014 class of

health law students "the most dynamic, brilliant, and
just plain fun group of health law students that I can
remember in recent history."
This ceremony marked the 17th year that the
L&HCP at the University of Maryland Carey School
of Law has been awarding the Health Law Certificate
to those students who have concentrated their legal
studies in the area of health law. Each student pursued
his or her interest in health law in a unique way and
each student's story is worth recounting but, given
the limits of space, in this article we focus on five
certificate students whose various backgrounds and
career aspirations highlight the breadth of health law
and its future practitioners.
Wandaly Esther Fernández
Everyone at the law school knows about Wandaly
Fernandez. Her contribution to the law school was
exemplary. In addition to earning the Health Law
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Certificate and serving as Manuscripts Editor of the
Journal of Health Care Law and Policy, Wandaly
was the President of the 2014 class. She was also the
only student member of the Dean’s Search Committee
this year and played a key role in selecting the law
school’s new dean – Donald Tobin. She participated
actively in the high powered group of faculty, alumni,
university officials and community leaders who
made up the search committee, and her judgments
were influential in shaping the thinking of the group.
Wandaly was also a member of the Moot Court
Board, a semi-finalist in the Myerowitz Moot Court
Competition, Co-Captain of the National Trial Team,
Peer Advisor, Admissions Ambassador and Rose
Zetzer Fellow. She impressed faculty and staff across
the law school with her unique leadership skills and
judgment. Wandaly, who earned her undergraduate
degree at the University of North Carolina, is now an
Associate at Epstein Becker Green in Washington DC
where she joins many other wonderful L&HCP alums
who remain active and involved in the program as
competition judges, mentors, and speakers at the law
school.

L&HCP Director Diane Hoffmann, 2014 Graduate Ian
Clark, Professor Ellen Weber

Brian Hall
Brian was a member of the L&HCP who became a
favorite of the faculty of the program. Professor Kathi
Hoke called him her “go-to student” in her Public
Health Law Clinic because of his insight and attention
to detail. He was also recognized as an incredibly
knowledgeable member of the team that represented

L&HCP Director Diane Hoffmann addressing 2014
Health Law Certificate Graduates

the law school at the Loyola University Chicago
Health Law Transactional Competition. With Brian’s
help, the team made a presentation at the competition
that one judge commented was so good it matched
the degree of difficulty he hoped to meet in his own
presentations. This deep knowledge of health law was
fostered by a Masters of Health Administration degree
Brian obtained from Cornell University. This gave
Brian a head start in health law that served him very
well. During law school, he served as a law clerk at
the Johns Hopkins Health System Legal Department,
a clerk in the office of U.S. Senator Lindsey Graham
working on issues relating to implementation of the
Affordable Care Act, and a health policy intern at
the American Society of Nuclear Cardiology. Like
Wandaly, Brian is also a first year Associate at Epstein
Becker Green where he promises to impress his
colleagues with a degree of expertise in health law
rarely seen with recent health law graduates.
Pari Rashmi Mody
Pari was one of many students in our program
whose science background drove their interest in the
intersection of law and biotechnology. Pari graduated
from Oberlin College with a BA in Biopsychology
and a concentration in Cognitive Science in 2006.
Prior to coming to the law school, she worked as a
researcher at Johns Hopkins and the University of
Pennsylvania. Her work in these labs resulted in coauthoring two scientific articles, “Rats Subjected to
Chronic-Intermittent Hypoxia (CIH) have Increased
Density of Noradrenergic Terminals in the Trigeminal
Sensory (Sp5) and Motor (Mo5) Nuclei” (505
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Neuroscience Letters 176–79 (2011)) and “Central but
not Basolateral Amygdala is Critical for Control of
Feeding by Aversive Conditioned Cues” (29 Journal
of Neuroscience 15205-12 (2009)). Pari pursued
her interest in science and the law at the law school
and, as a research assistant, was a very important
part of L&HCP Professor Amanda Pustilnik’s work
on neuroscience and the law for two years. Upon
graduation, Pari was named to the Order of the Coif.
She is now an associate at Squire Patton Boggs LLP.
James E. Valentine
James, who graduated in December 2013, was
(and still is) a critical member of the L&HCP
notwithstanding the fact that he was an evening
student with a demanding day job at the FDA. As
Co-President of SHLO during his second year,
James helped organize the inaugural Health Law
Regulatory and Compliance Competition. This
competition was a great success and has since grown
into a national competition. James also spearheaded
an L&HCP conference in partnership with Arnold &
Porter in Washington, DC, titled Emerging Issues in
Food and Drug Law: Implementation of FDASIA.
The conference focused on the Food and Drug
Administration Safety and Innovation Act (FDASIA)
and was geared to food and drug law practitioners.
The conference was a huge success. Now, as a
recently minted lawyer and Associate at Hyman,
Phelps, and McNamara PC, James continues to have
more hours in the day than his peers. He is helping
to organize the 4th annual regulatory competition that
he helped start in 2012 and is part of the planning
committee for the third Emerging Issues in Food and
Drug Law conference that will focus on the Drug
Quality and Security Act. The Act was passed by
Congress to respond to the October 2012 outbreak
of fungal meningitis that was traced to the poor
drug compounding practices of the New England
Compounding Center in Framingham, Massachusetts.
We are grateful for his continued participation in
our program and look forward to many years of
partnership.
Blake Walsh
Blake arrived at the law school with a BA in History
of Science and Medicine from Yale University. Her
undergraduate degree proved to be a perfect entry into

2014 Graduate Stephanie Noronha with her father and
Professor Sara Gold

2014 Graduates (from l to r) Stacy Siegel, Melanie Dang,
Blake Walsh, Wandaly Fernández

2014 Graduates (from l to r) Allan Thorson, Casey Rojas,
Mallory Montgomery, Leila Ameli-Grillon

15 │ Law & Health Care Newsletter

the L&HCP where she thrived. Like many of the other
students listed in this article, Blake was an integral
part of the L&HCP as Co-President of the Student
Health Law Organization in her second year. She was
Articles Editor of the Maryland Law Review in which
she published a Note titled “Lefemine v. Wideman:
Entrenching Judicial Confusion and Beckoning a More
Streamlined Analysis of First Amendment Violations
in the Anti-Abortion Protest Context.” Blake was
also appointed as a law clerk at the world-renowned
Cleveland Clinic after her second year. Blake’s

tireless dedication to her work was discussed during
the May 14 celebration breakfast. L&HCP Professor
Sara Gold told the attendees that Blake had to spend
her last Spring Break during law school combing
through over 1300 pages of medical documentation
and reorganizing exhibits for an upcoming trial. Her
sacrifice was rewarded in the end when she was able
to help her client gain full custody of his younger
brother. Blake continues to devote her boundless
energy to health law at Waller Lansden Dortch &
Davis LLP in Nashville.

2014 health law certificate recipients
Golnaz Alemousavi
Leila J. Ameli-Grillon
Lucy Brierly Bansal
Angelica Carliner
Travis Franklin Chance
Ian M. Clark
Melanie Dang
Aharon Dinovitz
Kristen Driggers
Wandaly Esther Fernández
Austin Foxwell
Patricia Greenwell
Martin Brian Hall, IV
Mario Hernandez-Gerety
Tereza Hess
Darby Hull

Megan Ix
Michalina Janik
Marta Kikena De Matto
Dana M. Krohn
Johanna Lister
Joanne Micheline Lucas
Nathan Whitmore McCurdy
Pari Rashmi Mody
Mallory Montgomery
Cindy Ann Nguyen
Bradley Nolet
Stephanie B. Noronha
Nkechi N. Nwaogu
Minyoung Park
Chelsea Person
Lauren Patrice Peterson
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William Rader
Sara Rigdon
Jorge E. Rodriguez
Casey Rojas
Philip H. Scharper, Jr.
Crystal D. Schroeder
Stacy Lynn Siegel
Eugene Albert Knight Simms
Patrick Stewart
Allan Robert Thorson
Amond Uwadineke
James E. Valentine
Abigail P. Walker
Blake Lauren Walsh
Darren H. Webb
Viola Anna Woolums

L&HCP Professor Kathi Hoke aka Iron woman
L&HCP Professor Kathi Hoke, whose scholarly accomplishments are detailed in this newsletter, has some equally impressive accomplishments that
take place outside of the law school. On September 20, Hoke completed the
Ironman Maryland triathlon. Her finishing time was 13 hours, 41 minutes,
37 seconds. The race consisted of a 2.4 mile swim in the Choptank River; a
112 mile bike ride that took her through the Blackwater Wildlife Refuge on
the Eastern Shore; and a 26.2 mile run through Cambridge, MD. The total
mileage is 140.6. This was the inaugural Ironman Maryland and Hoke’s first
full Ironman. She has always been a long distance runner but started doing
triathlons to celebrate turning 40 in 2007. She started with a sprint distance
at IronGirl and gradually built up to Olympic distance and Half Iron races
before tackling the full Ironman. She has done races in Maryland, Pennsylvania, Delaware, New Jersey, New York, and New Hampshire. Hoke said about
completing the event, “I feel incredibly grateful that my body and mind are
strong enough to indulge in these adventures and that my family, friends, students, and colleagues are supportive of the insanity. I went skydiving in May
and did Ironman in September; who knows what adventure lies ahead?”

Prof. Kathi Hoke and her son,
Dominic

Maryland Healthcare Ethics
Committee Network (MHECN) News
MHECN Grant Award to Study
MOLST Program
In September the Law & Health Care Program received word that the Maryland Office of Health Care
Quality (OHCQ) had awarded funding to MHECN
to evaluate the Maryland Medical Orders for LifeSustaining Treatment (MOLST) program. MHECN is
a membership organization for ethics committees at
health care institutions in Maryland and an initiative
of the Law & Health Care Program. The Maryland
MOLST evaluation study will determine whether
MOLST forms in Maryland health care institutions
are being used correctly and what impact the MOLST
program has had on end-of-life care for Marylanders
since the MOLST program went into effect statewide
in 2011.
Recognized as a “next generation” advance directive, MOLST programs have caught the attention of
communities around the country seeking to improve
end-of-life care. Currently more than 26 states have
implemented MOLST-like orders. The MOLST Program works by transforming life-sustaining treatment

preferences into medical orders that can be followed
by emergency medical technicians, nursing facility
staff, and other health professionals in times of crisis
and transition from one setting to the next. However,
the program’s success is dependent on appropriate
implementation. Evaluating how the MOLST form is
being used allows for identifying areas for improvement to achieve the goal of improving end-of-life care.
This evaluation study will address the following questions:
1. What is the rate of hospital compliance with
the MOLST-on-discharge obligation?
2. Is there evidence of some process underlying
completion of the MOLST form?
3. What is the MOLST form completion error
rate?
4. Is completion of the MOLST form complementing or replacing advance directive completion?
Data collection will take place this academic year and
results should be available by next fall.
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November 10 Conference
“Religious, Medical, Ethical and Legal Perspectives on
End of Life Issues”
The Law & Health Care Program’s Maryland Healthcare Ethics Committee Network (MHECN) is holding
a conference on November 10 in conjunction with the Institute for Jewish Continuity and the University of
Maryland Schools of Medicine, Nursing, Pharmacy, and Social Work. The conference, “Religious, Medical,
Ethical and Legal Perspectives on End of Life Issues,” will bring together faith representatives, bioethicists,
ethics committee members, and others to identify religious and ethical questions that arise in the care of patients
at the end of life and discuss strategies to help patients, family members, and health care providers navigate the
complexities of end of life decision-making. In addition to a discussion on “Religious Perspectives on ‘God's
Will,’” conference organizers will facilitate two interprofessional panels that will tackle these complex issues
from different professional perspectives. The conference is being organized by MHECN Program Coordinator,
Dr. Anita Tarzian, an Associate Professor at the University of Maryland School of Nursing in the Department of
Family and Community Health.

Evolution of Scholarship
Cont. from p. 11

a variety of settings. It is designed as both a teaching
tool and a resource for those interested in medical-legal partnerships. Professor Weimer’s chapter describes
the relationship between HIV, social determinants of
health such as poverty, race and sexual orientation,
and the law. It illustrates how an effective medical
legal partnership can—and has—addressed the many
barriers to care faced by people living with HIV. It
describes legal protections that have been enacted to
protect individuals and families affected by HIV that
at the same time can play a role in encouraging people
to be tested for HIV.
In the last three years, Professor Weimer has initiated a new clinic to focus particularly on housing issues
faced by people living with HIV. Substandard housing
in Baltimore poses a major health risk to individuals with chronic health problems including HIV and
asthma. These issues are described in a recent op-ed
piece written by Professor Weimer and published by
the Baltimore Sun in June titled “Justice Eludes Ten-

ants.”
Professor Weimer’s newest research focuses on the
impact that access to legal services can have on the
health and welfare of people living with HIV illness.
While an interdisciplinary approach to patient care in
the context of HIV is well accepted, little data exists
to measure the impact of integrating legal services
into an interdisciplinary care setting. Effective treatment for HIV is now available but among low income
people of color, poor health outcomes and deaths from
HIV-related causes still occur.
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fall 2014 Rome Lecture

Abbe Gluck
Professor, Yale Law School
The Challenges of the ACA in the Courts, the Congress and the States: The Legal-Political
Twists and Turns of the Most Controversial Statute in Modern Times
November 20, 2014
5 pm
Ceremonial Moot Court Room
University of Maryland Francis King Carey
School of Law
Reception following event

4th Annual Health Law Regulatory & Compliance
Competition: Call to Compete
The Health Law Regulatory & Compliance Competition is a unique and innovative competition that
challenges law students to navigate through the complex regulatory landscape of health care law, including
compliance with health care regulations and FDA law. It will be held on Saturday, February 21, 2015, from
approximately 8:00 a.m. until 3:00 p.m. at the University of Maryland Francis King Carey School of Law in
Baltimore, MD.

About the Competition:

The Competition requires teams of 2-3 students to analyze a hypothetical fact pattern involving various
interactions between health care stakeholders and entities participating in several health care activities that
necessitate regulatory and compliance oversight. The fact pattern will be given to teams the day of the
competition, and students will have approximately 1.5 hours to analyze the problem. Teams will then present
their findings and recommendations to a panel of practicing regulatory and compliance attorneys. The 4th
Annual Competition will focus on several interactions between various health care stakeholders, including
hospitals, physicians, drug and device manufacturers, and related third parties.

Call to Compete:

If you would like to have a team from your law school participate in the Competition, you can find additional
details and information about how to register at www.law.umaryland.edu/health/events/hlrc_competition.html.
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Law & Health Care Program
500 West Baltimore Street
Baltimore, MD 21201
www.law.umaryland.edu/healthlaw
Comments and letters should be
forwarded to the above address.

20 │ Law & Health Care Newsletter

